Patient Tumor-Derived Xenograft Models

BRI Biopharmaceutical Research Inc. Products

ALIVE Laboratories™ BRI is a Canadian commercial distributor of various cynomology and rhesus monkey and other non-human primate hepatocytes,

API / Clinical Product Quality Control, Dosing Solutions and Materials, Dose Formulation and Stability To support CMC development, BRI offers a

Bioanalytical Assays LC/MS/MS assays of drug candidates, metabolites and small molecule biomarkers in various biological matrices supporting clinical

BRIVAL™, in vitro drug metabolism A high-throughput in vitro cytochrome CYP450 assay for preclinical drug candidate metabolism screening.

Clinical Trial Equipment Rental & PK Sample Collection Kit Provide significant cost savings and logistic support for PK sample collection and storage

In Vitro DMPK & ADME BRIVAL™ is our in vitro drug metabolism group co-founded and operated by Dr. Albert P Li and Ms. Clara Faan, featuring a full

In Vivo DMPK & ADME The dried blood spot (DBS) sampling technique has allowed the sampling of 20 µL whole blood at each serial time point from a mouse

Oncograph™ Oncograph™, a unique patient-derived sub-renal capsule Xenograft efficacy mouse model

Patient Tumor-Derived Xenograft Models Oncograph™ is co-founded by a group of world experts in the area of cancer modeling, anti-cancer drug